Design and Synthesis of New Triazol Derivatives as Aromatase Enzyme Inhibitors
Chemical Biology & Drug Design · 2026-03 · 107 (3)
DOI: 10.1111/cbdd.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 12.03.2026. Verfasst von Abdullah Çelik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Eskişehir Osmangazi Unıversity Health, Practice and Research Hospital, Eskisehir, Turkey. Hauptthemen laut MEDLINE: Triazoles, Aromatase Inhibitors, Aromatase, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
In this study, novel triazole derivatives were designed and synthesized for potential breast cancer treatment. A series of 1,2,4‐triazole compounds bearing a 2,4‐difluorophenyl moiety ( 3a–3r ) was obtained through a two‐step organic synthesis process. The anticancer activities of the synthesized compounds were evaluated using the MTT assay in MCF‐7 and L929 cell lines, and some derivatives ( 3d, 3h, 3k, 3n ) exhibited selective cytotoxicity. The inhibitory effects of these compounds on the aromatase enzyme were determined and compared with those of letrozole. Molecular docking studies were performed to investigate the interactions of the most active compounds with the aromatase enzyme's active site, revealing binding energies and amino acid interactions. Finally, the ADME profiles of the lead compounds were assessed to analyze their pharmacokinetic properties. The findings suggest that the selected triazole derivatives may be promising novel candidates for aromatase inhibition in breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Eskişehir Osmangazi Unıversity Health, Practice and Research Hospital, Eskisehir, Turkey.
- Institute of Graduate Education, Anadolu University, Eskisehir, Turkey.
- Department of Biochemistry Sivas, Sivas Cumhuriyet University, Faculty of Pharmacy, Sivas, Turkiye.
- Medicinal Plant, Drug and Scientific Research and Application Center (AUBIBAM), Eskişehir, Turkey.
- Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
ORCID-Profile: Şennur Görgülü, Ulviye Acar Çevik
Zitieren
APA
Çelik, A., Bostancı, H. E., Görgülü, Ş., Yıldız, M. T., & Acar Çevik, U. (2026). Design and Synthesis of New Triazol Derivatives as Aromatase Enzyme Inhibitors. Chemical Biology & Drug Design, 107(3). https://doi.org/10.1111/cbdd.70276
Vancouver
Çelik A, Bostancı HE, Görgülü Ş, Yıldız MT, Acar Çevik U. Design and Synthesis of New Triazol Derivatives as Aromatase Enzyme Inhibitors. Chemical Biology & Drug Design. 2026;107(3). doi:10.1111/cbdd.70276
BibTeX
@article{elik2026,
author = {Çelik, Abdullah and Bostancı, Hayrani Eren and Görgülü, Şennur and Yıldız, Mehmet Taha and Acar Çevik, Ulviye},
title = {Design and Synthesis of New Triazol Derivatives as Aromatase Enzyme Inhibitors},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {3},
doi = {10.1111/cbdd.70276}
}
EUVIMED